Search results
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag
Reuters via Yahoo Singapore Finance· 4 months agoThe therapy was approved on Monday, in a first for children with a rare disorder called...
Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin
Zacks via Yahoo Singapore Finance· 9 months agoOrchard (ORTX) is set to be acquired by Kyowa Kirin for a consideration of $17 per American...
Kyowa Kirin to acquire Orchard Therapeutics for $478 million
Reuters via Yahoo Singapore Finance· 9 months agoTOKYO (Reuters) - Japanese pharmaceutical firm Kyowa Kirin said on Thursday it would acquire Britain-based biopharmaceutical company Orchard Therapeutics for $477.6 million, aiming to promote ...
Q4 2023 Ultragenyx Pharmaceutical Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Singapore Finance· 5 months agoParticipants Emil D. Kakkis; Founder, President, CEO & Director; Ultragenyx Pharmaceutical Inc. Eric Crombez; Chief Medical Officer & Executive VP; Ultragenyx Pharmaceutical Inc. Erik Harris ...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 8 months agoUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q3 2023 Earnings Call Transcript November 2, 2023...
Ultragenyx (RARE) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo Singapore Finance· 8 months agoUltragenyx (RARE) reports weaker-than-expected third-quarter 2023 results, missing earnings and...
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks via Yahoo Singapore Finance· 2 months agoUltragenyx (RARE) reports dismal first-quarter 2024 results, missing both earnings and revenue...
Orchard Therapeutics PLC Sponsored ADR (ORTX) Surges 96.0%: Is This an Indication of Further Gains?
Zacks via Yahoo Singapore Finance· 9 months agoOrchard Therapeutics PLC Sponsored ADR (ORTX) was a big mover last session on higher-than-average...
Ultragenyx (RARE) Sells Portion of Royalty Interest for $500M
Zacks via Yahoo News· 2 years agoUltragenyx (RARE) sells 30% of the royalty interest receivable on future North America sales of...
Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View
Zacks via Yahoo Singapore Finance· 2 years agoAmgen AMGN reported third-quarter 2022 earnings of $4.70 per share, which beat the Zacks Consensus...
